Penserra Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$178K Sell
2024
Q4
$1.14M Buy
2024
Q3
$171K Sell
2024
Q2
$2.62M Buy
2024
Q1
$2.17M Buy
2018
Q4
Sell
2018
Q3
$243K Buy
2018
Q2
$236K Buy
2018
Q1
$154K Buy
2017
Q4
$157K Buy
2017
Q3
$129K Buy